Heterodimeric antibodies that bind CD3 and GPC3
Provided herein are novel GPC3 binding domains, and antibodies that include such GPC3 binding domains (e.g., anti-GPC3×anti-CD3). Also provided herein are methods of using such antibodies for the treatment of GPC3-associated cancers.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
02.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are novel GPC3 binding domains, and antibodies that include such GPC3 binding domains (e.g., anti-GPC3×anti-CD3). Also provided herein are methods of using such antibodies for the treatment of GPC3-associated cancers. |
---|---|
Bibliography: | Application Number: US202217692045 |